文献速递血液净化与透析肾移植慢性肾脏病

居住地区预期寿命与终末期肾病患者结局及诊疗过程的关联

Residential Area Life Expectancy: Association With Outcomes and Processes of Care for Patients With ESRD in the United States.
PubMed 文献 · Am J Kidney Dis · 2018-03-07

本研究基于美国肾脏数据系统2006至2013年606,046例新发终末期肾病患者,回顾性分析居住县预期寿命与死亡、肾移植等待名单、移植及移植后结局的关联。结果显示,居住地预期寿命最低五分位患者死亡风险更高、等待名单和活体移植机会更低,且更少被告知移植、接受肾科医生诊疗或初始使用动静脉瘘。

要点

  • 居住地预期寿命最低五分位患者死亡风险显著升高(aHR 1.20)。
  • 低预期寿命地区患者进入等待名单和接受活体移植的机会显著降低。
  • 低预期寿命地区患者更少被告知移植、由肾科医生照护或初始使用动静脉瘘。

核心结论

  • 居住地区预期寿命作为社会经济、环境、遗传和行为因素的代理指标,与ESRD患者死亡及诊疗过程独立相关。
  • 这些结果强调患者居住环境对健康结局的潜在影响,独立于患者个体因素。

研究设计与样本

  • 回顾性队列研究,纳入美国肾脏数据系统2006至2013年新发成人ESRD患者606,046例。
  • 主要暴露为患者居住县由健康测量与评估研究所估算的预期寿命。

主要发现

  • 患者居住地预期寿命中位数男性75.6年、女性80.4年。
  • 与最高五分位相比,最低五分位调整后死亡HR为1.20(95%CI 1.18-1.22)。
  • 最低五分位进入等待名单aHR 0.68(95%CI 0.67-0.70),活体移植aHR 0.53(95%CI 0.51-0.56)。
  • 最低五分位移植后移植物丢失aHR 1.35(95%CI 1.27-1.43),移植后死亡aHR 1.29(95%CI 1.19-1.39)。
  • 低预期寿命地区患者更少被告知移植、由肾科医生照护或初始使用动静脉瘘。

临床怎么用

  • 临床评估ESRD患者时应考虑居住地区社会经济与环境因素对结局和诊疗过程的影响。

局限性

  • 可能存在残余混杂。
  • 基于居住地区数据推断个体效应存在局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effects of underlying noncodified risks are unclear on the prognosis of patients with end-stage renal disease (ESRD). We aimed to evaluate the association of residential area life expectancy with outcomes and processes of care for patients with ESRD in the United States. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Adult patients with incident ESRD between 2006 and 2013 recorded in the US Renal Data System (n=606,046). PREDICTOR: The primary exposure was life expectancy in the patient's residential county estimated by the Institute for Health Metrics and Evaluation. OUTCOMES: Death, placement on the kidney transplant wait list, living and deceased donor kidney transplantation, and posttransplantation graft loss. RESULTS: Median life expectancies of patients' residences were 75.6 (males) and 80.4 years (females). Compared to the highest life expectancy quintile and adjusted for demographic factors, disease cause, and multiple comorbid conditions, the lowest quintile had adjusted HRs for mortality of 1.20 (95% CI, 1.18-1.22); placement onto the waiting list, 0.68 (95% CI, 0.67-0.70); living donor transplantation, 0.53 (95% CI, 0.51-0.56); posttransplantation graft loss, 1.35 (95% CI, 1.27-1.43); and posttransplantation mortality, 1.29 (95% CI, 1.19-1.39). Patients living in areas with lower life expectancy were less likely to be informed about transplantation, be under the care of a nephrologist, or receive an arteriovenous fistula as the initial dialysis access. Results remained consistent with additional adjustment for zip code-level median income, population size, and urban-rural locality. LIMITATIONS: Potential residual confounding and attribution of effects to individuals based on residential area-level data. CONCLUSIONS: Residential area life expectancy, a proxy for socioeconomic, environmental, genetic, and behavioral factors, was independently associated with mortality and process-of-care measures for patients with ESRD. These results emphasize the underlying effect on health outcomes of the environment in which patients live, independent of patient-level factors. These findings may have implications for provider assessments.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Schold JD, Flechner SM, Poggio ED, et al. Residential Area Life Expectancy: Association With Outcomes and Processes of Care for Patients With ESRD in the United States. Am J Kidney Dis. 2018. PMID: 29525324. doi:10.1053/j.ajkd.2017.12.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。